Content area
Full Text
José A. Alda. 1 Child and Adolescent Psychiatry Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Daniel Muñoz-Samons. 1 Child and Adolescent Psychiatry Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Jordina Tor. 1 Child and Adolescent Psychiatry Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Jessica Merchán-Naranjo. 2 Child and Adolescent Psychiatry Department. Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.
Cecilia Tapia-Casellas. 2 Child and Adolescent Psychiatry Department. Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.
Inmaculada Baeza. 3 Child and Adolescent Psychiatry and Psychology, Neurosciences Institute, Hospital Clínic Universitari de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer ( IDIBAPS) , Barcelona, Spain.
Rosa Calvo-Escalona. 3 Child and Adolescent Psychiatry and Psychology, Neurosciences Institute, Hospital Clínic Universitari de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer ( IDIBAPS) , Barcelona, Spain.
Josefina Castro-Fornieles. 3 Child and Adolescent Psychiatry and Psychology, Neurosciences Institute, Hospital Clínic Universitari de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer ( IDIBAPS) , Barcelona, Spain. 4 Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain.
Carmen Martínez-Cantarero. 5 Child and Adolescent Psychiatry and Psychology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Patricia Andrés-Nestares. 5 Child and Adolescent Psychiatry and Psychology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Francisco Fernández-Avilés. 6 Department of Cardiology. Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.
Celso Arango. 2 Child and Adolescent Psychiatry Department. Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.
Funding: This work was supported by Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, CIBERSAM, grant from Fondo de Investigación Sanitaria (04/1690); Madrid Mental Health Association ("Miguel Angel Martín" Research Grant); "NARSAD 2005: Independent Investigator Award"; Alicia Koplowitz and Mutua Madrileña foundations; FP7 HEALTH F4-2010-241959 (Project PERS- Paediatric European Risperidone Studies), and the Ministries of Science and Innovation, Community of Madrid, Biomedical R&D funding S2010/BMD-2422 AGES (Madrid) for their support.
Address correspondence to: José A. Alda, MD, PhD, Child and Adolescent Psychiatry Department, Hospital Sant Joan de Déu, Passeig Sant Joan de Déu 2, CP 08950, Esplugues (Barcelona) Spain, E-mail: [email protected]
Introduction
The clinicians' perception that second-generation antipsychotics (SGA) are safer than first-generation...